| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.0095 | 1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |